Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Champions Oncolog (CSBR)

Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House ACCESS Newswire - Mon Apr 28, 4:45AM CDT

HACKENSACK, NJ / ACCESS Newswire / April 28, 2025 / Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in preclinical...

CSBR : 8.05 (+5.78%)
Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine ACCESS Newswire - Thu Apr 24, 3:00AM CDT

HACKENSACK, NJ / ACCESS Newswire / April 24, 2025 / Champions Oncology (NASDAQ:CSBR), a global leader in oncology R&D solutions, has announced a strategic collaboration with Turbine, the creators of the...

CSBR : 8.05 (+5.78%)
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million ACCESS Newswire - Tue Mar 11, 10:55AM CDT

HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today...

CSBR : 8.05 (+5.78%)
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025 ACCESS Newswire - Thu Mar 6, 10:00AM CST

HACKENSACK, NJ / ACCESS Newswire / March 6, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report...

CSBR : 8.05 (+5.78%)
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting ACCESS Newswire - Tue Feb 18, 3:00AM CST

HACKENSACK, NJ / ACCESS Newswire / February 18, 2025 / Champions Oncology Inc. (NASDAQ:CSBR), a global leader in preclinical oncology research and clinical specialty testing, today announced the acceptance...

CSBR : 8.05 (+5.78%)
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership ACCESS Newswire - Wed Jan 8, 2:00AM CST

HACKENSACK, NJ / ACCESSWIRE / January 8, 2025 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading technology-enabled oncology research organization with specialty testing services, is excited to announce...

CSBR : 8.05 (+5.78%)
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million ACCESS Newswire - Wed Dec 11, 2024

HACKENSACK, NJ / ACCESSWIRE / December 11, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today announced...

CSBR : 8.05 (+5.78%)
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024 ACCESS Newswire - Thu Dec 5, 2024

HACKENSACK, NJ / ACCESSWIRE / December 5, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report...

CSBR : 8.05 (+5.78%)
Champions Oncology Announces Agreement with Weill Cornell Medicine ACCESS Newswire - Wed Oct 16, 2024

HACKENSACK, NJ / ACCESSWIRE / October 16, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, is pleased to announce a licensing agreement...

CSBR : 8.05 (+5.78%)
Wall Street - New York Stock Exchange during sunrise by Deberarr via iStock
Stocks Rise Before the Open as Investors Await Key U.S. PPI Data, ECB Decision in Focus Barchart - Thu Sep 12, 2024

September S&P 500 E-Mini futures (ESU24) are up +0.24%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.27% this morning as investors braced for crucial U.S. producer inflation data while also...

ENPH : 34.92 (-23.97%)
NVDA : 144.12 (-0.39%)
ROG.Z.IX : 258.900 (-1.18%)
IPG : 23.01 (-2.00%)
NQU24 : 19,808.01s (-0.21%)
OXM : 42.40 (+1.24%)
MU : 120.34 (+0.42%)
FSLR : 143.90 (-17.89%)
PCH : 37.71 (-2.46%)
ALB : 59.69 (-2.08%)
ADBE : 382.68 (-4.74%)
ESU24 : 5,699.99s (-0.31%)

Barchart Exclusives

2 Option Ideas to Consider this Wednesday for Bearish Traders Barchart - 42 minutes ago
Today, we are using some moving average filters to find bullish stocks and then looking at a couple of different trade ideas. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot